phenytoin has been researched along with Fabry Disease in 7 studies
Fabry Disease: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neuropathic pain is one of the key features of (classical) Fabry disease (FD)." | 2.53 | Pain management strategies for neuropathic pain in Fabry disease--a systematic review. ( Biegstraaten, M; Hollak, CE; Linthorst, GE; Schuller, Y; Van Schaik, IN, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schuller, Y | 1 |
| Linthorst, GE | 1 |
| Hollak, CE | 1 |
| Van Schaik, IN | 1 |
| Biegstraaten, M | 1 |
| Török, L | 1 |
| Szekeres, L | 1 |
| Reszler, M | 1 |
| Sheth, KJ | 1 |
| Bernhard, GC | 1 |
| Atzpodien, W | 2 |
| Kremer, GJ | 2 |
| Schnellbacher, E | 1 |
| Denk, R | 1 |
| Haferkamp, G | 1 |
| Bierbach, H | 1 |
| Duperrat, B | 1 |
| Puissant, A | 1 |
| Saurat, JH | 1 |
| Delanoë, MJ | 1 |
| Doyard, PA | 1 |
| Grunfeld, JP | 1 |
| Igarashi, T | 1 |
| Sakuraba, H | 1 |
| Suzuki, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lipidomics and Functional Analyses of Platelets in Fabry Disease[NCT02649660] | 32 participants (Anticipated) | Observational | 2015-10-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for phenytoin and Fabry Disease
| Article | Year |
|---|---|
Pain management strategies for neuropathic pain in Fabry disease--a systematic review.
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Fabry Disease; Gabapentin; gamm | 2016 |
6 other studies available for phenytoin and Fabry Disease
| Article | Year |
|---|---|
[Angiokeratoma corporis diffusum (M. Fabry)].
Topics: Adult; Fabry Disease; Humans; Male; Phenytoin | 1980 |
The arthropathy of Fabry disease.
Topics: Adult; Fabry Disease; Finger Joint; Humans; Joints; Male; Neural Conduction; Pain; Phenytoin; Synovi | 1979 |
[Angiokeratoma corporis diffusum (Fabry's disease). Biochemical diagnosis in plasma].
Topics: Adult; Carbamazepine; Electrocardiography; Fabry Disease; Galactosidases; Glycolipids; Heterozygote; | 1975 |
[Fabry's diffuse angiokeratoma corporis].
Topics: Age Factors; Carbamazepine; Fabry Disease; Galactosidases; Glycolipids; Heterozygote; Humans; Kidney | 1975 |
[Proceedings: Fabry's disease, angiokeratomas present at birth. Effect of diphenylhydantoin on painful attacks].
Topics: Adult; Fabry Disease; Humans; Male; Phenytoin | 1975 |
Activation of platelet function in Fabry's disease.
Topics: Adolescent; Adult; alpha-Galactosidase; Carbamazepine; Child; Fabry Disease; Female; Heterozygote; H | 1986 |